ORENCIA
NDC 0003-2188 · E.R. Squibb & Sons, L.L.C.
Generic nameabatacept
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)ABATACEPT
Strength125 mg/mL
Pharmacologic classDecreased Cytokine Activity [PE], Recombinant Fusion Proteins [CS], Selective T Cell Costimulation Modulator [EPC]
Marketing categoryBLA
Packages
0003-2188-11 — 4 SYRINGE, GLASS in 1 CARTON (0003-2188-11) / 1 mL in 1 SYRINGE, GLASS
0003-2188-51 — 4 SYRINGE, GLASS in 1 CARTON (0003-2188-51) / 1 mL in 1 SYRINGE, GLASS
0003-2188-90 — 1 SYRINGE, GLASS in 1 CARTON (0003-2188-90) / 1 mL in 1 SYRINGE, GLASS
0003-2188-91 — 1 SYRINGE, GLASS in 1 CARTON (0003-2188-91) / 1 mL in 1 SYRINGE, GLASS
Billed under HCPCS
J0129 — Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) Medicare Part B payment limit (ASP + 6%): $45.86
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0003-2187 — abatacept, 0003-2814 — abatacept, 0003-2818 — abatacept